These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 1769475)
41. [Biochemical characteristics of toxic hepatitis]. Ishii H; Kato S; Ito D; Tsuchiya M Nihon Rinsho; 1985 Jun; 43(6):1139-43. PubMed ID: 2864460 [No Abstract] [Full Text] [Related]
42. [Recurrent cholestatic course of chronic aggressive hepatitis]. Erb W; Siede W Dtsch Med Wochenschr; 1969 May; 94(22):1145-50. PubMed ID: 5768539 [No Abstract] [Full Text] [Related]
43. [Acute drug-induced hepatitis]. Polunina TE Klin Med (Mosk); 1989 Oct; 67(10):87-90. PubMed ID: 2615317 [No Abstract] [Full Text] [Related]
44. Acute hepatitis due to brivudin: a case report. Mottu A; Rubbia-Brandt L; Bihl F; Hadengue A; Spahr L J Hepatol; 2009 Nov; 51(5):967-9. PubMed ID: 19692139 [TBL] [Abstract][Full Text] [Related]
45. Prolonged viral hepatitis type A with cholestasis: case report. Schiraldi O; Modugno A; Miglietta A; Fera G Ital J Gastroenterol; 1991; 23(6):364-6. PubMed ID: 1742530 [TBL] [Abstract][Full Text] [Related]
46. [Liver damage caused by laxatives. A contribution to the hepatotoxicity of 4,4'-(2-quinolylmethylene)-diphenol-hydrochloride]. Wiegelmann W; Borchard F; Irmscher K Arzneimittelforschung; 1975 Jun; 25(6):849-51. PubMed ID: 169854 [TBL] [Abstract][Full Text] [Related]
48. [Liver damage after administration of pyrazinamide in animal experiments. 3. Biochemical changes in liver tissue and blood serum]. Celikovská G; Stastná J; Zítková L; Brezinová H; Kürti V Arzneimittelforschung; 1970 Jan; 20(1):155-7. PubMed ID: 5467442 [No Abstract] [Full Text] [Related]
49. [Multivariant analysis of experimental liver damage: normal parameters of the rat serum]. Rauen HM; Schriewer H; Gebauer B; Abu Tair M; Rüther N; The LG Arzneimittelforschung; 1973 Jan; 23():Suppl:108-16. PubMed ID: 4740676 [No Abstract] [Full Text] [Related]
50. [Evaluation of the functional state of the liver in acute pancreatitis using several enzyme tests]. Synovets AS; Levitskiĭ AP; Michurin VF Klin Khir (1962); 1972 Jun; 6():4-8. PubMed ID: 5051059 [No Abstract] [Full Text] [Related]
51. Drug-induced liver injury: mechanisms, types and biomarkers. Vinken M; Maes M; Vanhaecke T; Rogiers V Curr Med Chem; 2013; 20(24):3011-21. PubMed ID: 23746274 [TBL] [Abstract][Full Text] [Related]
52. Drug induced hepatitis. Quak SH J Singapore Paediatr Soc; 1991; 33(1-2):25-30. PubMed ID: 1784106 [No Abstract] [Full Text] [Related]
54. [Hepatotoxicity of mianserin: a case with positive reintroduction]. Barbare JC; Biour M; Cadot T; Latrive JP Gastroenterol Clin Biol; 1992; 16(5):486-8. PubMed ID: 1526410 [No Abstract] [Full Text] [Related]
55. Liver injury associated with the use of Fructus Psoraleae (Bol-gol-zhee or Bu-gu-zhi) and its related proprietary medicine. Cheung WI; Tse ML; Ngan T; Lin J; Lee WK; Poon WT; Mak TW; Leung VK; Chau TN Clin Toxicol (Phila); 2009 Aug; 47(7):683-5. PubMed ID: 19640237 [TBL] [Abstract][Full Text] [Related]
56. Hepatotoxicity of mebendazole. Relationship with serum concentrations of the drug. Bekhti A; Pirotte J Gastroenterol Clin Biol; 1987 Oct; 11(10):701-3. PubMed ID: 3692093 [TBL] [Abstract][Full Text] [Related]
57. On the problem concerning the adaptation of the organism to repeated administration of a toxic agent in experiment. Vido I; Vido J Acta Hepatosplenol; 1965; 12(6):328-36. PubMed ID: 5868475 [No Abstract] [Full Text] [Related]